LEADER 01191nam--2200361---450-
001 990003270100203316
005 20090612111012.0
010   $a978-1-84720-599-5
035   $a000327010
035   $aUSA01000327010
035   $a(ALEPH)000327010USA01
035   $a000327010
100   $a20090612h2008----km-y0itay50------ba
101   $aeng
102   $aUS
105   $a||||||||001yy
200 1 $aCompetition law and patents$ea follow-on innovation perspective in the biopharmaceutical industry$fIrina Haracoglou
210   $aCheltenham, UK [etc.]$cEdward Elgar$dcopyr. 2008
215   $aXX, 251 p.$d24 cm
225 2 $aNew horizons in competition law and economics
410  0$12001$aNew horizons in competition law and economics
606 0 $aProprietà industriale$xLegislazione$2BNCF
676   $a341.758
700  1$aHARACOGLOU,$bIrina$0604842
801  0$aIT$bsalbc$gISBD
912   $a990003270100203316
951   $aXXIII.3.E 7$b59210 G.$cXXIII.3.E$d00226311
959   $aBK
969   $aGIU
979   $aIANNONE$b90$c20090612$lUSA01$h1110
979   $aCHIARA$b90$c20100419$lUSA01$h0951
996   $aCompetition law and patents$91119302
997   $aUNISA